Literature DB >> 17825100

Unsuspected multiples myeloma presenting as bilateral pleural effusion - a cytological diagnosis.

Kajal Kiran Dhingra1, Niti Singhal, Sonu Nigam, Shayama Jain.   

Abstract

BACKGROUND: Multiple Myeloma presenting as a pleural effusion is extremely rare. It is usually a late complication and is associated with a poor prognosis. CASE
PRESENTATION: A 40-year-old male presented with dyspnea and fever of six months duration. Clinical diagnosis of pulmonary tuberculosis was considered. X-ray chest showed bilateral pleural effusion. Pleural cytology revealed numerous plasma cells, some of which were binucleated and atypical. Cytological differential diagnosis included: Myelomatous effusion and Non-Hodgkin's Lymphoma deposit (Immunoblastic type). Bone marrow biopsy, serum protein electrophoresis and bone scan confirmed the diagnosis of multiple myeloma (Plasmablastic type).
CONCLUSION: Myelomatous pleural effusion as an initial presentation although extremely rare, should always be considered in presence of atypical plasma cells irrespective of age.

Entities:  

Year:  2007        PMID: 17825100      PMCID: PMC2000906          DOI: 10.1186/1742-6413-4-17

Source DB:  PubMed          Journal:  Cytojournal        ISSN: 1742-6413            Impact factor:   2.091


Background

Malignant pleural effusion in Multiple Myeloma (MM) is rare and seen in less than 1% of cases [1]. Identification of the atypical plasma cells in body fluids is important and may be missed when these are scant and mature appearing. Recognition of the atypical plasma cells in fluids is critical for therapeutic and prognostic considerations as this finding portends a poor prognosis [2]. Only eight cases have been reported so far, in which pleural effusion was the initial presentation [2-7]. We report atypical presentation of MM as bilateral pleural effusion in a younger age.

Case Presentation

A 40-year-old male presented with fever and dyspnea of six months duration. The physical examination and chest X-ray was suggestive of bilateral pleural effusion. A diagnostic pleural aspiration was performed from both the sides and cytospin preparation was made. Giemsa stained smears showed cellular smears comprising of many mature and immature plasma cells in a proteinaeous background. These cells had abundant dense blue cytoplasm, a large eccentric nucleus. Frequent binucleated and multinucleate forms, mitotic figures and scattered plasmablasts with prominent nucleoli were also seen (Fig. 1). Thus a diagnosis of Plasma cell dyscrasia versus Non-Hodgkin's Lymphoma (NHL-Immunoblastic type) was suggested. A skeletal survey, serum immunoelectropheresis, bone marrow aspiration and biopsy were advised to confirm the diagnosis. Radiological investigations revealed multiple osteolytic punched out lesions in the axial skeleton. His hemoglobin was 55 g/l; ESR was 85 mm in the first hour by Wintrobe method, and the peripheral smear showed marked rouleax formation. Serum protein electrophoresis showed a sharp M-spike in the IgG region. Bone marrow aspirate smears showed plasmacytoid cells with many binucleate forms. Bone marrow biopsy showed a suppressed hematopoiesis, thinned out bony trabeculae, and near total replacement of the marrow by plasma cells, 50% of which were plasmablastic type (Fig. 2). Based on the above features, a final diagnosis of Multiple Myeloma- Plasmablastic type (MMPT) was made.
Figure 1

Pleural fluid cytology- Many atypical plasma cells with prominent Nucleoli and binucleate forms are seen. (Giemsa stain × 400).

Figure 2

Bone marrow biopsy- sheets of plasma blasts with suppressed Hematopoiesis is seen. (Haematoxylin and Eosin stain × 400).

Pleural fluid cytology- Many atypical plasma cells with prominent Nucleoli and binucleate forms are seen. (Giemsa stain × 400). Bone marrow biopsy- sheets of plasma blasts with suppressed Hematopoiesis is seen. (Haematoxylin and Eosin stain × 400).

Discussion

Malignant myeloma is a clonal proliferation of plasma cells with multiple osteolytic lesions. It usually occurs in elderly patients (mean age 71 years) and presents with bone pains along with pathological fractures [8]. Malignant pleural effusion is usually a rare and late complication in the course of the disease [9]. Hence other etiologies of reactive pleural effusions like congestive heart failure, pneumonia, tuberculosis, collagen vascular disease, carcinomatosis, AIDS, other viral illness and pulmonary thromboembolism should be excluded before a diagnosis of malignant myelomatous effusion is made [9]. Cytologically these cases can have a predominantly lymphocytic infiltrate with scattered plasma cells showing atypical nuclear features. Differential diagnoses on cytology include other non-myelomatous effusions that present with pleural effusion e.g. NHL, acute and chronic lymphoid leukemias, especially those with concomitant mediastinal involvement [6]. The cytomorphology of the plasma cells along with the clinical profile are helpful in differentiating reactive from malignant plasma cell infiltrates. High cellularity with a predominant plasma cell population in a hemorrhagic or necrotic background favors a malignant effusion. Morphological features of malignant plasma cells are nuclear pleomorphism, prominent nucleoli, frequent mitosis and asynchronous maturation of the nucleus in relation to the cytoplasm. Pleural fluid electrophoresis, flow cytometry and immunocytochemistry aid in confirming the monoclonality of the plasma cells [9]. A malignant effusion in myeloma patients places the patient in advanced Salmon Durie stage. These patients are usually resistant to treatment and often relapse in spite of aggressive chemo-radiotherapy necessitating pleurodesis [2]. This finding suggests a dismal prognosis and death usually ensues within a few months. Therefore, recognition of the atypical plasma cells in the fluid is critical for therapeutic and prognostic considerations [9]. The present case is rare because the diagnosis was unsuspected in younger patient presenting with bilateral pleural effusion. The presence of atypical plasma cells in the body fluids should be carefully interpreted irrespective of the age and, the patient should be thoroughly assessed for MM. Because benign pleural effusions are common in MM patients, the diagnosis of serous cavity involvement by MM is critically important due to poor prognostic implications.

Conclusion

Myelomatous pleural effusion as an initial presentation although extremely rare, should always be considered in presence of atypical plasma cells irrespective of age. The diagnosis of serous cavity involvement by MM is critical due to poor prognostic implications and fluid cytology forms the mainstay of diagnosis.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

Dr Kajal and Dr Niti have assisted in the diagnosis of the case; the cytological work up was done by Dr Shayama Jain. The histopathological diagnosis was made by Dr Sonu Nigam. All authors have contributed in drafting and designing the manuscript and have read and approved of the final manuscript.
  9 in total

1.  Pleural effusion as an initial manifestation of multiple myeloma.

Authors:  A H Deshpande; M M Munshi
Journal:  Acta Cytol       Date:  2000 Jan-Feb       Impact factor: 2.319

2.  Co-incidental presentation of IgA lambda multiple myeloma and pleural involvement with IgM kappa non-Hodgkin's lymphoma.

Authors:  R Manley; J Monteath; W N Patton
Journal:  Clin Lab Haematol       Date:  1999-02

3.  [Multiple myeloma lambda IgG: myelomatous pleural effusion, an unusual presentation].

Authors:  M J Fernández González; A C Matía Cubillo; R González Sanz; I Juárez Redondo; A Jimeno Carrúez
Journal:  An Med Interna       Date:  2001-03

4.  [Pleural effusion as presentation form of multiple myeloma].

Authors:  R García Montesinos; N Avisbal Portillo; J L Velasco Garrido; C Rueda Ríos; J Bujalance Zafra; G Ramírez Ramírez
Journal:  Rev Clin Esp       Date:  2001-07       Impact factor: 1.556

5.  [Plasmocytic pleural effusion disclosing multiple myeloma].

Authors:  M Elloumi; M Frikha; H Masmoudi; S Mseddi; M Ben Ayed; M Bouaziz; F Makni; T Souissi
Journal:  Rev Mal Respir       Date:  2000-04       Impact factor: 0.622

6.  Pleural and pericardial effusion as the first sign of multiple myeloma.

Authors:  M André; J Ponsonnaille; J L Kemeny; M Filaire; P Travade; O Aumaitre
Journal:  Ann Med Interne (Paris)       Date:  1999-09

7.  Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends.

Authors:  H L Howe; P A Wingo; M J Thun; L A Ries; H M Rosenberg; E G Feigal; B K Edwards
Journal:  J Natl Cancer Inst       Date:  2001-06-06       Impact factor: 13.506

8.  Cytology and flow cytometry of malignant effusions of multiple myeloma.

Authors:  H E Palmer; C S Wilson; R H Bardales
Journal:  Diagn Cytopathol       Date:  2000-03       Impact factor: 1.582

9.  [Pleural effusion as a first sign of Ig D lambda multiple myeloma].

Authors:  Mustapha Maachi; Soraya Fellahi; Marie-Emilienne Diop; Thierry Francois; Jacqueline Capeau; Jean-Philippe Bastard
Journal:  Ann Med Interne (Paris)       Date:  2003-02
  9 in total
  10 in total

1.  Myelomatous Pleural Effusion: Case report and review of the literature.

Authors:  Khalil Al-Farsi; Ibrahim Al-Haddabi; Nafla Al-Riyami; Rashid Al-Sukaiti; Salam Al-Kindi
Journal:  Sultan Qaboos Univ Med J       Date:  2011-05-15

2.  Myelomatous pleural effusion as an initial sign of multiple myeloma-a case report and review of literature.

Authors:  Li-Li Zhang; Yuan-Yuan Li; Cheng-Ping Hu; Hua-Ping Yang
Journal:  J Thorac Dis       Date:  2014-07       Impact factor: 2.895

3.  CytoJournal's move to the new platform: More on financial model to the support open-access charter in cytopathology, publication quality indicators, and other issues.

Authors:  Vinod B Shidham; Martha B Pitman; Richard M Demay; Barbara F Atkinson
Journal:  Cytojournal       Date:  2008-12-16       Impact factor: 2.091

4.  A review of uncommon cytopathologic diagnoses of pleural effusions from a chest diseases center in Turkey.

Authors:  Ebru Cakir; Funda Demirag; Mehtap Aydin; Yurdanur Erdogan
Journal:  Cytojournal       Date:  2011-07-16       Impact factor: 2.091

5.  Myelomatous pleural effusion - Thoracoscopic evaluation of a rare entity.

Authors:  Chetan B Patil; Neeraj Gupta; Rakesh C Gupta; Ramakant Dixit; Ankur Gupta; Varna Indushekar
Journal:  Lung India       Date:  2015 Sep-Oct

6.  Myelomatous pleural effusion-A case report.

Authors:  J Miller; P A Alton
Journal:  Respir Med Case Rep       Date:  2011-10-14

7.  Solitary pleural myeloma diagnosed by semi-rigid thoracoscopy: A case report and literature review.

Authors:  Jin-Sheng Ouyang; Yu-Ping Li; Peng Li; Min Ye; Jun-Ru Ye; Bei-Bei Wang; Ying Zhou; Cheng-Shui Chen
Journal:  Mol Clin Oncol       Date:  2016-08-23

8.  Myelomatous pleural effusion: A rare case entity reported from a tertiary care cancer center in South India.

Authors:  Govind K Babu; Smitha C Saldanha; K N Lokesh; M C Suresh Babu; Akkamaha Devi Patil; Pretesh R Kiran; K C Lakshmaiah; D Lokanatha
Journal:  Lung India       Date:  2017 Mar-Apr

9.  A case of bilateral pleural effusion as the first sign of multiple myeloma.

Authors:  Xuan-li Xu; Yi-hong Shen; Qian Shen; Jian-ying Zhou
Journal:  Eur J Med Res       Date:  2013-03-20       Impact factor: 2.175

10.  Cytology of plasma cell rich effusion in cases of plasma cell neoplasm.

Authors:  Debasis Gochhait; Pranab Dey; Neelam Verma
Journal:  J Cytol       Date:  2016 Jul-Sep       Impact factor: 1.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.